Commercialization Group Intended To Speed Time To Market, Merck Says
This article was originally published in The Pink Sheet Daily
Merck's new supply initiative includes creating a new commercialization organization that will operate under the manufacturing division, Manufacturing Division President Willie Deese said during a Nov. 28 conference call announcing Merck's restructuring plans
You may also be interested in...
The company suggests future restructuring efforts could address R&D, marketing and sales after unveiling the first phase of its restructuring initiative.
The firm’s acute migraine treatment Nurtec ODT generated $65m in 2020 after launching a year ago. Biohaven aims for Nurtec to become the leader in what could be a $4bn-$5bn category in the US.